This inventor holds 1 USPTO granted patent. Top assignee: The General Hospital Corporation. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Innovations by Hubert E Blum in Viral Replication Inhibition
Introduction
Hubert E Blum is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of virology, particularly in the methods of preventing viral replication. His work focuses on innovative approaches to combat viral infections, including hepatitis B.
Latest Patents
One of Hubert E Blum's key patents is titled "Methods of preventing viral replication." This invention relates to methods and compositions for the inhibition of viral replication. Specifically, it addresses the termination of replication of the hepatitis B virus by introducing into a target cell an antisense oligonucleotide. This oligonucleotide has a sequence that is substantially complementary to an mRNA, which in turn is complementary to a portion of the minus strand of the hepatitis viral genome. This portion encodes solely part or all of the terminal protein region of the viral polymerase. Hubert holds 1 patent in this area.
Career Highlights
Hubert E Blum is associated with The General Hospital Corporation, where he applies his expertise in virology and patent development. His work has been instrumental in advancing the understanding and treatment of viral infections.
Collaborations
Hubert collaborates with Tsanyang Jake Liang, who is also involved in research related to viral replication and its inhibition. Their combined efforts contribute to the ongoing advancements in this critical area of medical research.
Conclusion
Hubert E Blum's innovative work in the field of viral replication inhibition showcases his dedication to improving health outcomes through scientific research. His contributions are vital in the fight against viral infections, particularly hepatitis B.